Skip to content
10-Q

Quarterly Report

NUNZIA PHARMACEUTICAL COMPANY

0001683168-22-006728

← back to feed
Filed
Oct 3, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2022 · Sep 30, 2022 434.51M sh
Shares Diluted Q2 2022 · Jun 30, 2022 434.19M sh
Shares Diluted Q2 2022 · Jun 30, 2022 434.12M sh
Shares Diluted Q2 2022 · Jun 30, 2021 289.15M sh
Shares Diluted Q2 2022 · Jun 30, 2021 286.98M sh
Operating Cash Flow Q2 2022 · Jun 30, 2022 −$77.57K
Stockholders Equity Q2 2022 · Jun 30, 2022 −$117.41K
Stockholders Equity Q2 2022 · Mar 31, 2022 −$132.3K
Stockholders Equity Q2 2022 · Dec 31, 2021 −$94.17K
Stockholders Equity Q2 2022 · Mar 31, 2021 −$78.85K
Current Liabilities Q2 2022 · Jun 30, 2022 $147.34K
Current Liabilities Q2 2022 · Dec 31, 2021 $99.31K
Total Liabilities Q2 2022 · Jun 30, 2022 $147.34K
Total Liabilities Q2 2022 · Dec 31, 2021 $99.31K
Total Assets Q2 2022 · Jun 30, 2022 $29.94K
Total Assets Q2 2022 · Dec 31, 2021 $5.13K
Eps Diluted Q2 2022 · Jun 30, 2022 $0.00
Eps Diluted Q2 2022 · Jun 30, 2022 −$0.04
Eps Diluted Q2 2022 · Jun 30, 2021 $0.00
Eps Diluted Q2 2022 · Jun 30, 2021 $0.00
Eps Basic Q2 2022 · Jun 30, 2022 $0.00
Eps Basic Q2 2022 · Jun 30, 2022 −$0.04
Sga Expense Q2 2022 · Jun 30, 2022 $20.1K
Sga Expense Q2 2022 · Jun 30, 2022 $38.49K
Net Income Q2 2022 · Jun 30, 2022 −$20.1K
Net Income Q2 2022 · Jun 30, 2022 −$18.74M
Net Income Q2 2022 · Mar 31, 2022 −$18.72M
Operating Income Q2 2022 · Jun 30, 2022 −$20.1K
Operating Income Q2 2022 · Jun 30, 2022 −$18.74M
Revenue Q2 2022 · Jun 30, 2022 $0
Revenue Q2 2022 · Jun 30, 2022 $0